Cargando…
NAD+ Precursors and Intestinal Inflammation: Therapeutic Insights Involving Gut Microbiota
The oxidized form of nicotinamide adenine dinucleotide (NAD+) is a critical metabolite for living cells. NAD+ may act either as a cofactor for many cellular reactions as well as a coenzyme for different NAD+-consuming enzymes involved in the physiological homeostasis of different organs and systems....
Autores principales: | Niño-Narvión, Julia, Rojo-López, Marina Idalia, Martinez-Santos, Patricia, Rossell, Joana, Ruiz-Alcaraz, Antonio J., Alonso, Núria, Ramos-Molina, Bruno, Mauricio, Didac, Julve, Josep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10346866/ https://www.ncbi.nlm.nih.gov/pubmed/37447318 http://dx.doi.org/10.3390/nu15132992 |
Ejemplares similares
-
NAD+ Precursors: A Physiological Reboot?
por: Niño-Narvión, Julia, et al.
Publicado: (2023) -
The Bittersweet Beat: Diabetes Complications
por: Rossell, Joana, et al.
Publicado: (2023) -
Nicotinamide Prevents Diabetic Brain Inflammation via NAD+-Dependent Deacetylation Mechanisms
por: Torres-Méndez, Jeimy Katherine, et al.
Publicado: (2023) -
Predictive Value of the Advanced Lipoprotein Profile and Glycated Proteins on Diabetic Retinopathy
por: Julve, Josep, et al.
Publicado: (2022) -
Association of α-klotho with subclinical carotid atherosclerosis in subjects with type 1 diabetes mellitus
por: Castelblanco, Esmeralda, et al.
Publicado: (2022)